Clinical Trial Update: Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hypofractionated radiotherapy with hyperthermia for unresectable or marginally resectable soft tissue sarcomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Sarcoma, Alveolar Soft Part Sarcoma | Phase 2 | Status: UNKNOWN